Mono Pharmacare Exempt from Corporate Governance Report for Q1 FY27
Mono Pharmacare Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 8:53 pm
Mono Pharmacare Exempt from Corporate Governance Report for Q1 FY27 Mono Pharmacare Limited announced that it is exempt from submitting the Corporate Governance Report under Regulation 27(2) of SEBI (LODR) Regulations, 2015, for the quarter ended 30th Jun'26. The exemption applies pursuant to Regulation 15(2)(b) of Chapter IV, as the company鈥檚 equity shares are listed on the SME exchange platform.
Original exchange filing (PDF)
More announcements from Mono Pharmacare Ltd
- MONOPHARMA : 21-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 14, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 21, 2026, To consider and approve the financial results for the period ended September 30, 2026 路 21 Nov 2026
- Mono Pharmacare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Mono Pharmacare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026-27 路 27 Oct 2026
- Integrated filing governance for quarter 2 2026-27 路 27 Oct 2026
- Integrated filing governance for quarter 1 2026-27 路 15 Oct 2026
- Mono Pharmacare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 02 Oct 2026
- Mono Pharmacare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 路 30 Sept 2026
